Recombinant Human VEGF165

Recombinant Human VEGF165

Size1:10μg price1:$140
Size2:50μg price2:$369
SKU: PCH2544 Category: Cytokines Tags: ,

Datasheet

Name

Recombinant Human Vitronectin

Purity

Greater than 98% as determined by reducing SDS-PAGE

Endotoxin level

≤1 EU/mg

Construction

Recombinant Human Vitronectin is produced by our Mammalian cell expression system and the target gene encoding Asp20-Leu478 is expressed.

Accession #

P04004

Host

Human Cells

Species

Human

Predicted Molecular Mass

52.3 kDa

Buffer

Lyophilized From PBS,5% mannitol and 0.01% Tween 80, pH7.4

Form

Shipping

The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below.

Stability&Storage

Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

Reconstitution

Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

 

 

 

Alternative Names

Vitronectin; VN; S-Protein; Serum-Spreading Factor; V75; VTN

 

Background

Vitronectin is also known as S-protein, VN, VTN, V75. Vitronectin, a multifunctional glycoprotein, is involved in coagulation, inhibition of the formation of the membrane attack complex (MAC), cell adhesion and migration, wound healing, and tissue remodeling. The primary cellular source of vitronectin is hepatocytes. Blocking of Hic(a member of the pneumococcal surface protein C (PspC) family) by specific antiserum or genetic deletion significantly reduced pneumococcal binding to soluble and immobilised vitronectin and to Factor H, respectively. In addition, Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway.

 

Note

For Research Use Only , Not for Diagnostic Use.